Jundishapur Journal of Microbiology

Published by: Kowsar

The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes

Ahmad Niknam 1 , Mohammad Hossein Karimi 1 , * , Ramin Yaghobi 1 , Bita Geramizadeh 1 , Jamshid Roozbeh 1 , Mehdi Salehipour 1 and Mahdiyar Iravani 1
Authors Information
1 Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: August 01, 2016, 9 (8); e31338
  • Published Online: February 17, 2016
  • Article Type: Research Article
  • Received: July 7, 2015
  • Revised: October 26, 2015
  • Accepted: November 28, 2015
  • DOI: 10.5812/jjm.31338

To Cite: Niknam A, Karimi M H, Yaghobi R, Geramizadeh B, Roozbeh J, et al. The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes, Jundishapur J Microbiol. 2016 ; 9(8):e31338. doi: 10.5812/jjm.31338.

Abstract
Copyright © 2016, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Erdbruegger U, Scheffner I, Mengel M, Schwarz A, Verhagen W, Haller H, et al. Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies. Nephrol Dial Transplant. 2012; 27(1): 435-43[DOI][PubMed]
  • 2. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002; 34(8): 1094-7[DOI][PubMed]
  • 3. Reusser P, Cathomas G, Attenhofer R, Tamm M, Thiel G. Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load. J Infect Dis. 1999; 180(2): 247-53[DOI][PubMed]
  • 4. Brennan DC. Cytomegalovirus in renal transplantation. J Am Soc Nephrol. 2001; 12(4): 848-55[PubMed]
  • 5. Chen SL, Morgan TR. The natural history of hepatitis C virus (HCV) infection. Int J Med Sci. 2006; 3(2): 47-52[PubMed]
  • 6. Aroldi A, Lampertico P, Montagnino G, Lunghi G, Passerini P, Villa M, et al. Natural history of hepatitis C virus infection in adult renal graft recipients. Transplant Proc. 2005; 37(2): 940-1[DOI][PubMed]
  • 7. Einollahi B, Pourfarziani V, Ahmadzad-Asl M, Davoudi F, Lessan-Pezeshki M, Davoudi A, et al. Iranian model of renal allograft transplantation in 3028 recipients: survival and risk factors. Transplant Proc. 2007; 39(4): 907-10[DOI][PubMed]
  • 8. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Hepatitis C virus antibody status and survival after renal transplantation: meta-analysis of observational studies. Am J Transplant. 2005; 5(6): 1452-61[DOI][PubMed]
  • 9. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: an update. Am J Kidney Dis. 2003; 42(4): 631-57[PubMed]
  • 10. Pedroso S, Martins L, Fonseca I, Dias L, Henriques AC, Sarmento AM, et al. Impact of hepatitis C virus on renal transplantation: association with poor survival. Transplant Proc. 2006; 38(6): 1890-4[DOI][PubMed]
  • 11. Kusztal M, Koscielska-Kasprzak K, Drulis-Fajdasz D, Magott-Procelewska M, Patrzalek D, Janczak D, et al. The influence of CTLA-4 gene polymorphism on long-term kidney allograft function in Caucasian recipients. Transpl Immunol. 2010; 23(3): 121-4[DOI][PubMed]
  • 12. Lee KM, Chuang E, Griffin M, Khattri R, Hong DK, Zhang W, et al. Molecular basis of T cell inactivation by CTLA-4. Science. 1998; 282(5397): 2263-6[PubMed]
  • 13. Jiang Z, Chen Y, Feng X, Xie H, Zhou L, Zheng S. Recipient cytotoxic T lymphocyte antigen 4 +49 single-nucleotide polymorphism is not associated with acute rejection after liver transplantation in Chinese population. Int J Med Sci. 2013; 10(3): 250-4[DOI][PubMed]
  • 14. Bernard D, Hansen JD, Du Pasquier L, Lefranc MP, Benmansour A, Boudinot P. Costimulatory receptors in jawed vertebrates: conserved CD28, odd CTLA4 and multiple BTLAs. Dev Comp Immunol. 2007; 31(3): 255-71[DOI][PubMed]
  • 15. Collins M, Ling V, Carreno BM. The B7 family of immune-regulatory ligands. Genome Biol. 2005; 6(6): 223[DOI][PubMed]
  • 16. Sharpe AH, Freeman GJ. The B7-CD28 superfamily. Nat Rev Immunol. 2002; 2(2): 116-26[DOI][PubMed]
  • 17. Lafage-Pochitaloff M, Costello R, Couez D, Simonetti J, Mannoni P, Mawas C, et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics. 1990; 31(3): 198-201[PubMed]
  • 18. Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics. 2001; 78(3): 155-68[DOI][PubMed]
  • 19. Andres PG, Howland KC, Nirula A, Kane LP, Barron L, Dresnek D, et al. Distinct regions in the CD28 cytoplasmic domain are required for T helper type 2 differentiation. Nat Immunol. 2004; 5(4): 435-42[DOI][PubMed]
  • 20. Eagar TN, Karandikar NJ, Bluestone JA, Miller SD. The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance. Eur J Immunol. 2002; 32(4): 972-81[DOI][PubMed]
  • 21. Douroudis K, Laine AP, Heinonen M, Hermann R, Lipponen K, Veijola R, et al. Association of CTLA4 but not ICOS polymorphisms with type 1 diabetes in two populations with different disease rates. Hum Immunol. 2009; 70(7): 536-9[DOI][PubMed]
  • 22. Perez-Garcia A, De la Camara R, Roman-Gomez J, Jimenez-Velasco A, Encuentra M, Nieto JB, et al. CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors. Blood. 2007; 110(1): 461-7[DOI][PubMed]
  • 23. Zhang G, Liu Z, Duan S, Han Q, Li Z, Lv Y, et al. Association of polymorphisms of programmed cell death-1 gene with chronic hepatitis B virus infection. Hum Immunol. 2010; 71(12): 1209-13[DOI][PubMed]
  • 24. Karimi MH, Motazedian M, Geramizadeh B, Nikeghbalian S, Yaghobi R, Abedi F, et al. Association of the Co-stimulatory Molecules Polymorphisms with CMV Infection in Liver Transplant Recipients. Int J Organ Transplant Med. 2011; 2(4): 171-7[PubMed]
  • 25. Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, Blum HE, et al. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol. 2006; 80(7): 3532-40[DOI][PubMed]
  • 26. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006; 443(7109): 350-4[DOI][PubMed]
  • 27. Velu V, Kannanganat S, Ibegbu C, Chennareddi L, Villinger F, Freeman GJ, et al. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol. 2007; 81(11): 5819-28[DOI][PubMed]
  • 28. Yee LJ, Perez KA, Tang J, van Leeuwen DJ, Kaslow RA. Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection. J Infect Dis. 2003; 187(8): 1264-71[DOI][PubMed]
  • 29. Thio CL, Mosbruger TL, Kaslow RA, Karp CL, Strathdee SA, Vlahov D, et al. Cytotoxic T-lymphocyte antigen 4 gene and recovery from hepatitis B virus infection. J Virol. 2004; 78(20): 11258-62[DOI][PubMed]
  • 30. Krichen H, Sfar I, Jendoubi-Ayed S, Makhlouf M, Ben Rhomdhane T, Bardi R, et al. Genetic polymorphisms of immunoregulatory proteins in acute renal allograft rejection. Transplant Proc. 2009; 41(8): 3305-7[DOI][PubMed]
  • 31. Gorgi Y, Sfar I, Abdallah TB, Abderrahim E, Ayed SJ, Aouadi H, et al. Ctla-4 exon 1 (+49) and promoter (-318) gene polymorphisms in kidney transplantation. Transplant Proc. 2006; 38(7): 2303-5[DOI][PubMed]
  • 32. Kim HJ, Jeong KH, Lee SH, Moon JY, Lee TW, Kang SW, et al. Polymorphisms of the CTLA4 gene and kidney transplant rejection in Korean patients. Transpl Immunol. 2010; 24(1): 40-4[DOI][PubMed]
  • 33. Solez K, Colvin RB, Racusen LC, Haas M, Sis B, Mengel M, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant. 2008; 8(4): 753-60[DOI][PubMed]
  • 34. Dilmec F, Ozgonul A, Uzunkoy A, Akkafa F. Investigation of CTLA-4 and CD28 gene polymorphisms in a group of Turkish patients with colorectal cancer. Int J Immunogenet. 2008; 35(4-5): 317-21[DOI][PubMed]
  • 35. Haimila K, Smedberg T, Mustalahti K, Maki M, Partanen J, Holopainen P. Genetic association of coeliac disease susceptibility to polymorphisms in the ICOS gene on chromosome 2q33. Genes Immun. 2004; 5(2): 85-92[DOI][PubMed]
  • 36. Ferreiros-Vidal I, Gomez-Reino JJ, Barros F, Carracedo A, Carreira P, Gonzalez-Escribano F, et al. Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects. Arthritis Rheum. 2004; 50(8): 2590-7[DOI][PubMed]
  • 37. Liu X, Hu LH, Li YR, Chen FH, Ning Y, Yao QF. Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population. Rheumatol Int. 2011; 31(2): 209-13[DOI][PubMed]
  • 38. Wang L, Li D, Fu Z, Li H, Jiang W, Li D. Association of CTLA-4 gene polymorphisms with sporadic breast cancer in Chinese Han population. BMC Cancer. 2007; 7: 173[DOI][PubMed]
  • 39. Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta Neurol Scand. 2009; 120(6): 424-9[DOI][PubMed]
  • 40. Hartmann A, Sagedal S, Hjelmesaeth J. The natural course of cytomegalovirus infection and disease in renal transplant recipients. Transplantation. 2006; 82(2 Suppl)-7[DOI][PubMed]
  • 41. Birk PE, Chavers BM. Does cytomegalovirus cause glomerular injury in renal allograft recipients? J Am Soc Nephrol. 1997; 8(11): 1801-8[PubMed]
  • 42. Burke GW, 3rd, Kaufman DB, Millis JM, Gaber AO, Johnson CP, Sutherland DE, et al. Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results. Transplantation. 2004; 77(8): 1269-75[PubMed]
  • 43. Haimila K, Turpeinen H, Alakulppi NS, Kyllonen LE, Salmela KT, Partanen J. Association of genetic variation in inducible costimulator gene with outcome of kidney transplantation. Transplantation. 2009; 87(3): 393-6[DOI][PubMed]
  • 44. La Rosa C, Limaye AP, Krishnan A, Longmate J, Diamond DJ. Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease. J Infect Dis. 2007; 195(5): 633-44[DOI][PubMed]
  • 45. Saadi MI, Yaghobi R, Karimi MH, Geramizadeh B, Ramzi M, Zakerinia M. Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients. Mol Biol Rep. 2013; 40(10): 5833-42[DOI][PubMed]
  • 46. Gavin M, Rudensky A. Control of immune homeostasis by naturally arising regulatory CD4+ T cells. Curr Opin Immunol. 2003; 15(6): 690-6[PubMed]
  • 47. Xiao H, Luo Y, Lai X, Fu S, Shi J, Tan Y, et al. Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies. Haematologica. 2012; 97(12): 1804-12[DOI][PubMed]
  • 48. Idris ZM, Miswan N, Muhi J, Mohd TA, Kun JF, Noordin R. Association of CTLA4 gene polymorphisms with lymphatic filariasis in an East Malaysian population. Hum Immunol. 2011; 72(7): 607-12[DOI][PubMed]
  • 49. June CH, Ledbetter JA, Linsley PS, Thompson CB. Role of the CD28 receptor in T-cell activation. Immunol Today. 1990; 11(6): 211-6[PubMed]
  • 50. Turka LA, Ledbetter JA, Lee K, June CH, Thompson CB. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J Immunol. 1990; 144(5): 1646-53[PubMed]
  • 51. Krichen H, Sfar I, Ben Abdallah T, Bardi R, Abderrahim E, Jendoubi-Ayed S. Kidney Transplantation - New Perspectives. 2011; : 111-26
  • 52. Wassink L, Vieira PL, Smits HH, Kingsbury GA, Coyle AJ, Kapsenberg ML, et al. ICOS expression by activated human Th cells is enhanced by IL-12 and IL-23: increased ICOS expression enhances the effector function of both Th1 and Th2 cells. J Immunol. 2004; 173(3): 1779-86[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments